Sinomab Bioscience Limited (4VF)
Market Closed
19 Aug, 17:31
XDUS XDUS Primary €
0. 12
+0
+2.4793%
€
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 0.12
Previous Close Want to track 4VF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinomab Bioscience Limited (4VF) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.79M
Trailing P/E (ttm) -1.37
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.2
Overview
Shares outstanding 1.39B
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.1
52-Week high 0.22
Beta -
50-Day moving average 0.12
200-Day moving average 0.15
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.12%
Return on equity -0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -104.98M
Diluted EPS (ttm) -0.09
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 200.93M
Total cash per share (mrq) -
Total debt (mrq) 338.49M
Total Debt/Equity (mrq) 0.67
Current ratio (mrq) 1.91%
Book value per share (mrq) -
Cash Flow
Cash flow statement -70.48M
Levered free cash flow (LFCF) -104.98M
